Advertisement
UK markets close in 3 hours 4 minutes
  • FTSE 100

    8,092.06
    +47.25 (+0.59%)
     
  • FTSE 250

    19,796.89
    -2.83 (-0.01%)
     
  • AIM

    755.20
    +0.33 (+0.04%)
     
  • GBP/EUR

    1.1639
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2441
    -0.0012 (-0.09%)
     
  • Bitcoin GBP

    53,578.43
    +447.73 (+0.84%)
     
  • CMC Crypto 200

    1,441.35
    +17.25 (+1.21%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.00
    -0.36 (-0.43%)
     
  • GOLD FUTURES

    2,326.70
    -15.40 (-0.66%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,188.05
    +50.40 (+0.28%)
     
  • CAC 40

    8,144.64
    +38.86 (+0.48%)
     

BUZZ-Scancell: drug problem spurs worst day in 3 yrs

** Drug developer Scancell's shares down 27 pct, worst day in nearly three years, after suspends dosing in a cancer clinical trial because of quality problems with its immunotherapy treatment SCIB1

** Co says current supplies of drug no longer meet original specification and are no longer suitable for further use

** The suspension affects 8 patients in a clinical trial, co says

** Shares (Berlin: DI6.BE - news) at 6-mth lows, with more than 10x their 30-day avg vols gone through in the first half hour of trade (venkateshasoumithri.mamidipudi.thomsonreuters.com@reuters.net)